According to a company press release, Mr. Binney will replace interim CEO Arthur Taylor, who will return as a member of the company’s board of directors. Mr. Binney was most recently president and general manager of interventional urology at Teleflex and has more than 20 years of experience in medical device leadership.
Relievant is preparing for increased growth with the addition of the Intracept procedure, a form of treatment for people experiencing chronic low back pain.
“Tyler is a proven leader and has a long and successful history of bringing disruptive medical devices to market. We look forward to leveraging his experience accelerating growth through commercial execution, product innovation, and the building of strong, integrated teams,” said Richard Mott, executive board chair of Relievant. “With an unparalleled level of clinical evidence supporting Intracept’s position in the CLBP care pathway and a Category I CPT code effective in January 2022, Relievant is poised for its next phase of growth — and Tyler brings the right blend of experience and expertise to lead the Company at this important stage.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.